These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A group-sequential design for clinical trials with treatment selection. Stallard N; Friede T Stat Med; 2008 Dec; 27(29):6209-27. PubMed ID: 18792085 [TBL] [Abstract][Full Text] [Related]
4. Eligibility exclusions, losses to follow-up, removal of randomized patients, and uncounted events in cancer clinical trials. Gail MH Cancer Treat Rep; 1985 Oct; 69(10):1107-13. PubMed ID: 4042091 [TBL] [Abstract][Full Text] [Related]
5. [Problems in conducting clinical trials for cancer patients]. Kondo M Gan To Kagaku Ryoho; 1996 Jan; 23(2):151-5. PubMed ID: 8611042 [TBL] [Abstract][Full Text] [Related]
6. Dose selection in seamless phase II/III clinical trials based on efficacy and safety. Kimani PK; Stallard N; Hutton JL Stat Med; 2009 Mar; 28(6):917-36. PubMed ID: 19152231 [TBL] [Abstract][Full Text] [Related]
7. [Data management for clinical trials at the data center]. Niimi M; Fukuda H; Yamamoto S; Okuyama S; Yamaguchi N Gan To Kagaku Ryoho; 1998 Jan; 25(2):253-9. PubMed ID: 9474934 [TBL] [Abstract][Full Text] [Related]
9. Factors influencing the evaluation of an article in cancer literature. Kumaraswamy ; Supe SS; Ramesh C Indian J Cancer; 1999; 36(2-4):69-79. PubMed ID: 10921210 [TBL] [Abstract][Full Text] [Related]
10. Intermittent hormone therapy and its place in the contemporary endocrine treatment of prostate cancer. Shaw G; Oliver RT Surg Oncol; 2009 Sep; 18(3):275-82. PubMed ID: 19269165 [TBL] [Abstract][Full Text] [Related]
11. Clinical trial design for adenoviral gene therapy products. Shirakawa T Drug News Perspect; 2009 Apr; 22(3):140-5. PubMed ID: 19440556 [TBL] [Abstract][Full Text] [Related]
12. [The progress of second-line chemotherapy and molecular targeting agents in gastric cancer]. Takiuchi H Gan To Kagaku Ryoho; 2009 May; 36(5):717-20. PubMed ID: 19461169 [TBL] [Abstract][Full Text] [Related]
14. [A qualified clinical trial system for cancer chemotherapy, an urgent motion]. Inokuchi K Gan To Kagaku Ryoho; 2002 May; 29(5):815-24. PubMed ID: 12040692 [TBL] [Abstract][Full Text] [Related]
15. Methodology of superficial bladder cancer trials: objective evaluation of treatment - the need for standardization. Bassi PF; Volpe A; Racioppi M; D'Agostino D; Gardi M; Totaro A; Pinto F; Sacco E; Bongiovanni L Urol Int; 2009; 83(3):258-63. PubMed ID: 19829021 [TBL] [Abstract][Full Text] [Related]
16. Guidelines for publishing papers on cancer clinical trials: responsibilities of editors and authors. Zelen M Prog Clin Biol Res; 1983; 132E():57-68. PubMed ID: 6647489 [No Abstract] [Full Text] [Related]
17. [An index of understanding randomised clinical trials in oncology]. Leroy T; Christophe V; Penel N; Antoine P; Vanlemmens L; Reich M; Clisant S Bull Cancer; 2009 Jun; 96(6):741-50. PubMed ID: 19467958 [TBL] [Abstract][Full Text] [Related]
18. Fraud in breast-cancer trials. Broder S N Engl J Med; 1994 May; 330(20):1460-1. PubMed ID: 8159208 [No Abstract] [Full Text] [Related]
19. Publication outcomes of phase II oncology clinical trials. Hoeg RT; Lee JA; Mathiason MA; Rokkones K; Serck SL; Crampton KL; Emmel AE; Severson EA; Go RS Am J Clin Oncol; 2009 Jun; 32(3):253-7. PubMed ID: 19349853 [TBL] [Abstract][Full Text] [Related]
20. Imatinib: a second look. Longer follow-up in chronic myeloid leukaemia: clear advantages. Prescrire Int; 2008 Dec; 17(98):226-8. PubMed ID: 19415889 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]